Catalyst Wire Dossier Catalyst Wire Dossier

Saroglitazar

saroglitazar · Zydus Therapeutics Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Saroglitazar, covering 2014-10-16 to 2025-10-24. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver Disease [Phase 1]

See pricing